Who has invested in Neurosterix?

Perceptive Xontogeny Venture Fund II are named among the investors backing Neurosterix.

Neurosterix Funding: $63M Raised, Series A (2024)

Neurosterix funding overview

Neurosterix is based in Geneva, Switzerland. Neurosterix has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Neurosterix runs through 2024; nothing later has been disclosed. Investors on record include Perceptive Xontogeny Venture Fund II.

Neurosterix at a glance

Total raised: $63M
Latest round: Series A
Latest round date: January 2024
Headquarters: Geneva, Switzerland
Notable investors: Perceptive Xontogeny Venture Fund II

Frequently asked about Neurosterix funding

How much has Neurosterix raised?: Neurosterix has raised $63M in total disclosed funding across the rounds on record.
Who has invested in Neurosterix?: Perceptive Xontogeny Venture Fund II are named among the investors backing Neurosterix.
What was the latest Neurosterix funding round?: The most recent disclosed round is a Series A, announced in January 2024.
Where is Neurosterix based?: Neurosterix is based in Geneva, Switzerland.
When did Neurosterix last raise?: The last disclosed Neurosterix round closed in January 2024 at Series A.

Neurosterix totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Geneva below to benchmark round size and investor mix.

Neurosterix Funding: $63M Raised, Series A (2024)

Neurosterix funding overview

Neurosterix at a glance

Frequently asked about Neurosterix funding

Companies related to Neurosterix (40)

Browse related funding lists (3)